focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
(Alliance News) - Construction firm Galliford Try on Wednesday reported a fall in annual profit and sliced its dividend by a quarter.
Revenue for the year to June 30 fell 7.5% to GBP2.71 billion from GBP2.93 billion, with pretax profit dipping 27% to GBP104.7 million from GBP143.7 million.
The company cut its full-year dividend 25% to 58.0p from 77.0p.
Galliford said its construction result for the year was hit by challenges in both legacy projects and some current one, though the business continues to see "good demand" in its Building and Infrastructure divisions, which are part of Galiford's Construction arm.
On Tuesday, Bovis Homes said it had resumed talks to acquire Galliford Try's housebuilding businesses.
Galliford Chief Executive Graham Prothero said on Wednesday: "The potential combination of our Linden Homes and Partnerships businesses with Bovis Homes represents a superb opportunity, enhancing the prospects for all three of our businesses to thrive as strategically focused and well-financed operations with excellent opportunities for growth. The transaction allows Construction to continue trading as a standalone well capitalised business."
Sone knowledge of physics helps to understand that there is no theoretical basis for low energy nuclear fusion.
Note also that there has been no peer reviewed publication supporting the claim and ALL attempts at reproducing the experiment has failed.
As terrible as this Tories government (to us a word somewhat loosely) is, my takeaway from the EU election results is that Labour under JC can not win a GE. At best they would need coalition partners to gain office. In my view this means that the nationalisation threat has been removed. If that is the case then NG is undervalued.
For the sake of balance let me say that IMHO the Conservative Party will not be back in power in my life time.
I will be looking at market opinion before I add to my holdings.
I also have substantial holdings in those companies but have MRK and IBT (and others) (24% in this sector)
MRK because of keytruda and IBT for exposure to new biotech developments. Novo Nordisk because of the "epidemic of type II diabetes sweeping through Asia.
LONDON (Alliance News) - Woodford Patient Capital Trust PLC on Monday said its portfolio company Evofem Inc reported positive results from the phase 3 clinical trial of contraceptive Amphora.
As of the end of October, Evofem represented a 0.4% position in Woodford Patient Capital Trust's portfolio.
The trust said the prevention of pregnancy drug Amphora successfully met its primary endpoint. Evofem believes that Amphora will now enable health care providers to offer patients an effective birth control method that is "non-hormonal, on-demand, and woman-controlled".
The efficacy, safety and subject satisfaction with Amphora was assessed in 1,400 healthy women aged between 18 and 35 years at 112 centres in the US. The study demonstrated that when Amphora is used as directed, the efficacy in which women can have confidence is similar to other frequently used contraceptive methods.
Biotechnology company Evofem intends to submit the Amphora new drug application to the US Food & Drug Administration in the second quarter of 2019. If approved, it plans to commercialise this birth control treatment in January 2020.
MELBOURNE (Alliance News) - BHP Group PLC said Monday it successfully completed the off-market buyback of Australian-listed BHP Group Ltd shares and announced a USD1.02 per share special dividend, both to return money to shareholders from the sale of the miner's US oil assets.
BHP said the final transaction size of AUD7.3 billion, about GBP4.2 billion, has enabled BHP Group Ltd to buy back approximately 265.8 million shares, which represents 8.3% of the issued share capital of BHP Group Ltd and 5.0% of the total issued capital of BHP Group Ltd and BHP Group PLC.
The price for the buyback was set at AUD27.64 per share. The stock was trading at AUD33.53 in Sydney on Monday.
In addition, BHP declared a special dividend of USD1.02 per share, which will be paid to all BHP shareholders as of January 11, 2019.
The special dividend represents the residual USD5.2 billion of net proceeds from BHP's sale of its onshore US assets not returned via the buyback.